ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2020

Model-based Prediction of the Long-term Glucose-Lowering Effects of Ipragliflozin, a Selective Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor, in Patients with Type 2 Diabetes Mellitus.

Masako Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.